Identification of categories at risk for high quality of life impairment in patients with vitiligo

British Journal of Dermatology

Volumn 159, Issue 2, 2008, Pages 351-359

  Sampogna, F ^a   Raskovic, D ^a   Guerra, L ^a   Pedicelli, C ^a   Tabolli, S ^a   Leoni, L ^a   Alessandroni, L ^a   Abeni, D ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Psychology; Quality of life; Questionnaire; Vitiligo

Indexed keywords

ADULT; AGE; ALEXITHYMIA; ANGER; ANXIETY; ARTICLE; DEPRESSION; DISEASE SEVERITY; EMBARRASSMENT; EMOTION; FAMILY HISTORY; FEMALE; GENDER; GENERAL HEALTH QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RISK; SHAME; SOCIAL LIFE; TORONTO ALEXITHYMIA SCALE; VITILIGO; WORRY;

ADOLESCENT; ADULT; AGE FACTORS; ATTITUDE TO HEALTH; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITILIGO;

EID: 47549086681     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08678.x     Document Type: Article

References (27)

1. Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007 20 : 27 35.
2. Papadopoulos L, Bor R, Legg C et al. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol 1998 23 : 243 8.
3. Ongenae K, Beelaert L, van Geel N et al. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol 2006 20 : 1 8.
4. Hautmann G, Panconesi E. Vitiligo: a psychologically influenced and influencing disease. Clin Dermatol 1997 15 : 879 90.
5. Firooz A, Bouzari N, Fallah N et al. What patients with vitiligo believe about their condition. Int J Dermatol 2004 43 : 811 14.
6. Ongenae K, van Geel N, De Schepper S et al. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005 152 : 1165 72.
7. Porter JR, Beuf AH, Lerner A et al. Psychosocial effect of vitiligo: a comparison of vitiligo patients with 'normal' control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986 15 : 220 4.
8. Kent G, al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996 21 : 330 3.
9. Ongenae K, Dierckxsens L, Brochez L et al. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005 210 : 279 85.
10. Fortune DG, Main CJ, O'Sullivan TM et al. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997 137 : 755 60.
11. Sampogna F, Sera F, Abeni D. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004 122 : 602 7.
12. Lewis VJ, Finlay AY. A critical review of quality-of-life scales for psoriasis. Dermatol Clin 2005 23 : 707 16.
13. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997 136 : 305 14.
14. Abeni D, Picardi A, Pasquini P et al. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002 204 : 43 9.
15. Chren MM, Lasek RJ, Quinn LM et al. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997 108 : 103 7.
16. Bellantuono C, Fiorio R, Zanotelli R et al. Psychiatric screening in general practice in Italy. A validity study of the GHQ (General Health Questionnaire). Soc Psychiatry 1987 22 : 113 17.
17. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. London : Oxford University Press, 1972.
18. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale - I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994 38 : 23 32.
19. Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale - II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994 38 : 33 40.
20. Bressi C, Taylor G, Parker J et al. Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res 1996 41 : 551 9.
21. Zachariae R, Zachariae C, Ibsen HH et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol (Stockh) 2004 84 : 205 12.
22. Sampogna F, Chren MM, Melchi CF et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006 154 : 325 31.
23. Sampogna F, Picardi A, Chren MM et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004 66 : 620 4.
24. Honkalampi K, Hintikka J, Tanskanen A et al. Depression is strongly associated with alexithymia in the general population. J Psychosom Res 2000 48 : 99 104.
25. Mattila AK, Salminen JK, Nummi T et al. Age is strongly associated with alexithymia in the general population. J Psychosom Res 2006 61 : 629 35.
26. Picardi A, Abeni D, Renzi C et al. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol (Stockh) 2001 81 : 410 14.
27. Boehncke WH, Ochsendorf F, Paeslack I et al. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol 2002 12 : 577 80.